Page last updated: 2024-08-21

erythromycin and Ventricular Fibrillation

erythromycin has been researched along with Ventricular Fibrillation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Sterneberg, M1
Guslits, B; MacDonald, LL; Orban, Z; Peters, MA1
de Koning, J; Hamer, B; Thompson, J; van der Hoeven, H1

Other Studies

3 other study(ies) available for erythromycin and Ventricular Fibrillation

ArticleYear
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2018, 10-01, Volume: 20, Issue:10

    Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Antazoline; Anti-Bacterial Agents; Arrhythmias, Cardiac; Disease Models, Animal; Erythromycin; Histamine H1 Antagonists; Isolated Heart Preparation; Long QT Syndrome; Membrane Transport Modulators; Pinacidil; Rabbits; Refractory Period, Electrophysiological; Sotalol; Torsades de Pointes; Ventricular Fibrillation

2018
Erythromycin-induced cardiac toxicity.
    The American journal of cardiology, 1995, Apr-15, Volume: 75, Issue:12

    Topics: Adult; Arrhythmia, Sinus; Bradycardia; Cardiac Complexes, Premature; Erythromycin; Female; Humans; Hypotension; Injections, Intravenous; Torsades de Pointes; Ventricular Fibrillation

1995
Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia.
    The Netherlands journal of medicine, 1994, Volume: 44, Issue:4

    Topics: Aged; Erythromycin; Female; Humans; Legionnaires' Disease; Torsades de Pointes; Ventricular Fibrillation

1994